Literature DB >> 35622489

APC/C Cdh1p and Slx5p/Slx8p ubiquitin ligases confer resistance to aminoglycoside hygromycin B in Saccharomyces cerevisiae.

Philip J Smaldino1, Jason D True1, Ashley L Kalinski1, Ellen M Doss1, Mary E Tragesser-Tiña1, Yanru Huang1, Eric M Rubenstein1.   

Abstract

Entities:  

Year:  2022        PMID: 35622489      PMCID: PMC9007615          DOI: 10.17912/micropub.biology.000547

Source DB:  PubMed          Journal:  MicroPubl Biol        ISSN: 2578-9430


× No keyword cloud information.
(A-C) Sixfold serial dilutions of yeast with indicated genotypes were spotted onto agar plates containing rich growth medium lacking (No Drug) or supplemented with indicated concentrations of hygromycin B. Plates were incubated at 30°C and imaged after 1-2 days. Experiments were performed in triplicate.

Description

The ubiquitin-proteasome system (UPS) mediates both regulatory and quality control protein degradation (Finley et al., 2012; Kleiger and Mayor, 2014). In the UPS, ubiquitin ligase enzymes covalently attach multiple copies of the small protein ubiquitin to substrate proteins. Polyubiquitylated proteins are degraded by the 26S proteasome. Several ubiquitin ligases contribute to the degradation of nuclear proteins in Saccharomyces cerevisiae (Breckel and Hochstrasser, 2021). The integral membrane Doa10p ubiquitin ligase resides in the inner nuclear and endoplasmic reticulum (ER) membranes and targets both nuclear and ER proteins for degradation (Ravid et al., 2006; Swanson et al., 2001). Doa10p substrates include naturally short-lived proteins and misfolded polypeptides (Huyer et al., 2004; Swanson et al., 2001). The heterotrimeric transmembrane Asi ubiquitin ligase (comprised of Asi1p, Asi2p, and Asi3p) resides in the inner nuclear membrane (Foresti et al., 2014; Khmelinskii et al., 2014). The Asi complex promotes turnover of mislocalized and misfolded soluble and transmembrane proteins (Foresti et al., 2014; Khmelinskii et al., 2014; Natarajan et al., 2020). By virtue of the location of their substrate clientele, Doa10p and the Asi complex are said to mediate inner nuclear membrane-associated degradation (INMAD). We previously demonstrated that yeast lacking DOA10 , ASI1 , and ASI3 (but not ASI2 ) exhibit compromised growth in the presence of hygromycin B (Crowder et al., 2015; Niekamp et al., 2019; Runnebohm et al., 2020; Woodruff et al., 2021), an aminoglycoside produced by Streptomyces hygroscopicus . Hygromycin B impairs translational fidelity by causing ribosome aminoacyl site distortion, resulting in the production of incorrectly synthesized polypeptides (Brodersen et al., 2000; Ganoza and Kiel, 2001). Sensitivity of a mutant to hygromycin B is consistent with contribution of the mutated gene’s product to protein quality control (PQC ) (Bengtson and Joazeiro, 2010; Crowder et al., 2015; Verma et al., 2013). In this study, we evaluated hygromycin B sensitivity of yeast strains with mutations in genes encoding subunits of two soluble ubiquitin ligases, APC/C Cdh1p and Slx5p/Slx8p, that also target nuclear substrates. The anaphase-promoting complex/cyclosome (APC/C) is a multi-subunit soluble ubiquitin ligase that mediates turnover of cell cycle-regulated proteins (e.g. cyclins) (Irniger et al., 1995; Sudakin et al., 1995). APC/C target specificity is determined by the identity of a coactivator subunit, which can be either Cdh1p or Cdc20p (Visintin et al., 1997). APC/C Cdh1p targets both cytoplasmic and nuclear proteins for degradation and regulates the mitosis-to-G1 transition (Schwab et al., 1997; Visintin et al., 1997). APC/C Cdh1p was recently shown to promote the turnover of an integral inner nuclear membrane protein in yeast, expanding the panel of ubiquitin ligases that participate in INMAD (Koch et al., 2019). Whether APC mediates PQC in addition to regulatory protein degradation is unknown. The Slx5p/Slx8p heterodimer was initially characterized as a SUMO (Small Ubiquitin-like MOdifier)-targeted ubiquitin ligase (STUbL), marking for degradation proteins that have first been SUMOylated (Uzunova et al., 2007; Xie et al., 2007). Subsequent studies demonstrated a subset of Slx5p/Slx8p substrates are targeted in a SUMO-independent manner (Xie et al., 2010). Like Doa10p and the Asi complex, Slx5p/Slx8p promotes regulatory protein turnover (e.g. degradation of yeast transcription factor MATα2p (Xie et al., 2010) and SUMO ligase Siz1 (Westerbeck et al., 2014)) and degradation of aberrant proteins (e.g. destruction of a mutated variant of the Mot1p transcription factor (Wang and Prelich, 2009)). The extent to which Slx5p/Slx8p contributes to PQC relative to other nuclear ubiquitin ligases is uncharacterized. To investigate potential contributions of APC/C Cdh1p and Slx5p/Slx8p to PQC, we cultured wild type yeast and yeast lacking DOA10 , ASI1 , CDH1 , SLX5 , or SLX8 in the absence or presence of increasing concentrations of hygromycin B (Figure 1A). All strains exhibited similar growth in the absence of hygromycin B. As previously observed (Woodruff et al., 2021), doa10Δ and asi1Δ yeast exhibited marked sensitivity to hygromycin B. Loss of CDH1 sensitized yeast to hygromycin B to a similar extent as DOA10 or ASI1 deletion. SLX5 and SLX8 deletion also compromised hygromycin B resistance. slx8Δ yeast exhibited modestly greater sensitivity to hygromycin B than slx5Δ yeast. To validate the observation that CDH1 deletion impairs yeast growth in the presence of hygromycin B, we compared growth of independently generated yeast possessing or lacking CDH1 (Koch et al., 2019) (Figure 1B). These strains also expressed the inner nuclear membrane APC/C Cdh1p substrate Mps3p tagged with the V5 epitope. Consistent with data in Figure 1A, CDH1 deletion diminished resistance to hygromycin B. To validate the observations made with slx5Δ and slx8Δ yeast, we analyzed growth of independently generated strains of a distinct genetic background lacking SLX5 and SLX8 , individually and in combination (Figure 1C). Indeed, slx5Δ yeast, slx8Δ yeast, and slx5Δ slx8Δ yeast each exhibited reduced resistance to hygromycin B. No substantial difference in sensitivity for yeast lacking SLX5 and SLX8 was observed, suggesting the differences in fitness of slx5Δ and slx8Δ yeast observed in our initial experiment (Figure 1A) may reflect genetic background-specific idiosyncrasies. Our results indicate APC/C Cdh1p and Slx5p/Slx8p are both critical for optimal fitness in the presence of hygromycin B, which is associated with increased concentrations of aberrant proteins. This is consistent with prominent roles for both ubiquitin ligases in PQC (although our data do not formally exclude non-catalytic function of these proteins in mitigating hygromycin B toxicity). Previous reports established contributions of Slx5p/Slx8p to nuclear PQC (e.g. (Wang and Prelich, 2009)). Further, Slx5p and Slx8p mitigate toxicity associated with polyglutamine-expanded huntingtin protein (Ohkuni et al., 2018). To our knowledge, a role for APC/C Cdh1p in PQC has not been suggested. In addition to well-characterized roles in cell cycle-regulated degradation of nuclear and cytoplasmic substrates, our data imply APC/C Cdh1p may also contribute to destruction of misfolded or otherwise aberrant proteins. Consistent with a role for APC/C Cdh1p in PQC, negative genetic relationships between CDH1 and SLX5 , SLX8 , and HRD3 (which encodes a component of the ER PQC HRD ubiquitin ligase) have been detected in large-scale genetic interaction studies (Costanzo et al., 2010; Costanzo et al., 2016; Pan et al., 2006). The nature of aberrancies and subcellular localization of putative APC/C Cdh1p PQC substrates remains to be determined. In mediating cell cycle progression, Cdh1p recruits APC/C to substrates possessing D-Box and KEN box degradation signals (Burton and Solomon, 2001). Conceivably, translational infidelity induced by hygromycin B could result in the appearance of motifs resembling these degrons in incorrectly synthesized polypeptide molecules; alternatively, APC/C Cdh1p may exhibit broader substrate specificity than previously appreciated. We note that loss of CDH1 is synthetically lethal with more than 20 genes (e.g. (Gallegos et al., 2020)). Thus, it is also possible that misfolding and dysfunction of a subset of these gene products (induced by hygromycin B) is lethal in the context of CDH1 deletion. Each of the ubiquitin ligases in this study (Doa10p, Asi complex, APC/C Cdh1p , and Slx5p/Slx8p) promotes regulatory degradation and possesses characterized or implied (based on this study) roles in PQC. To cope with the staggering number of ways protein molecules may conceivably misfold, become damaged, or behave aberrantly, we speculate many ubiquitin ligases with characterized function in regulatory protein turnover (such as APC/C Cdh1p ) moonlight in PQC.

Methods

Yeast growth experiments were performed as previously described (Watts et al., 2015). Four μl of sixfold serial dilutions were spotted onto agar plates containing yeast extract-peptone-dextrose medium (Guthrie and Fink, 2004) lacking or possessing hygromycin B (Gibco) at indicated concentrations. Plates were incubated at 30°C and imaged on the indicated days. Name Genotype Figure Reference VJY6 (alias MHY500) MATa his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 1C (Chen et al., 1993) VJY102 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 doa10Δ::kanMX4 1A (Tong et al., 2001) VJY360 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 asi1Δ::kanMX4 1A (Tong et al., 2001) VJY476 (alias BY4741) MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 1A (Tong et al., 2001) VJY643 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 slx5Δ::kanMX4 1A (Tong et al., 2001) VJY659 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 slx8Δ::kanMX4 1A (Tong et al., 2001) VJY660 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdh1Δ::kanMX4 1A (Tong et al., 2001) VJY921 (alias HY5850) MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 V5-MPS3 1B (Koch et al., 2019) VJY922 (alias HY5901) MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdh1Δ::kan V5-MPS3 1B (Koch et al., 2019) VJY987 (alias MHY3712) MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx5Δ::kan 1C (Xie et al., 2010) VJY988 (alias MHY3716) MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx8Δ::kan 1C (Xie et al., 2010) VJY989 (alias MHY3861) MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx5Δ::kan slx8Δ::kan 1C (Xie et al., 2010)

Reagents

Table 1. Yeast strains used in this study.

Name

Genotype

Figure

Reference

VJY6 (alias MHY500)

MATa his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2

1C

(Chen et al., 1993)

VJY102

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 doa10Δ::kanMX4

1A

(Tong et al., 2001)

VJY360

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 asi1Δ::kanMX4

1A

(Tong et al., 2001)

VJY476 (alias BY4741)

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

1A

(Tong et al., 2001)

VJY643

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 slx5Δ::kanMX4

1A

(Tong et al., 2001)

VJY659

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 slx8Δ::kanMX4

1A

(Tong et al., 2001)

VJY660

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdh1Δ::kanMX4

1A

(Tong et al., 2001)

VJY921 (alias HY5850)

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 V5-MPS3

1B

(Koch et al., 2019)

VJY922 (alias HY5901)

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdh1Δ::kan V5-MPS3

1B

(Koch et al., 2019)

VJY987 (alias MHY3712)

MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx5Δ::kan

1C

(Xie et al., 2010)

VJY988 (alias MHY3716)

MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx8Δ::kan

1C

(Xie et al., 2010)

VJY989 (alias MHY3861)

MAT α his3-Δ200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 slx5Δ::kan slx8Δ::kan

1C

(Xie et al., 2010)

  36 in total

1.  SUMO-independent in vivo activity of a SUMO-targeted ubiquitin ligase toward a short-lived transcription factor.

Authors:  Yang Xie; Eric M Rubenstein; Tanja Matt; Mark Hochstrasser
Journal:  Genes Dev       Date:  2010-04-13       Impact factor: 11.361

2.  A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation.

Authors:  R Swanson; M Locher; M Hochstrasser
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

3.  Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways.

Authors:  Tommer Ravid; Stefan G Kreft; Mark Hochstrasser
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

Review 4.  Perilous journey: a tour of the ubiquitin-proteasome system.

Authors:  Gary Kleiger; Thibault Mayor
Journal:  Trends Cell Biol       Date:  2014-01-20       Impact factor: 20.808

5.  Growth-based determination and biochemical confirmation of genetic requirements for protein degradation in Saccharomyces cerevisiae.

Authors:  Sheldon G Watts; Justin J Crowder; Samuel Z Coffey; Eric M Rubenstein
Journal:  J Vis Exp       Date:  2015-02-16       Impact factor: 1.355

6.  Systematic genetic analysis with ordered arrays of yeast deletion mutants.

Authors:  A H Tong; M Evangelista; A B Parsons; H Xu; G D Bader; N Pagé; M Robinson; S Raghibizadeh; C W Hogue; H Bussey; B Andrews; M Tyers; C Boone
Journal:  Science       Date:  2001-12-14       Impact factor: 47.728

7.  The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.

Authors:  V Sudakin; D Ganoth; A Dahan; H Heller; J Hershko; F C Luca; J V Ruderman; A Hershko
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

8.  A DNA integrity network in the yeast Saccharomyces cerevisiae.

Authors:  Xuewen Pan; Ping Ye; Daniel S Yuan; Xiaoling Wang; Joel S Bader; Jef D Boeke
Journal:  Cell       Date:  2006-02-16       Impact factor: 41.582

9.  Ubiquitin-dependent proteolytic control of SUMO conjugates.

Authors:  Kristina Uzunova; Kerstin Göttsche; Maria Miteva; Stefan R Weisshaar; Christoph Glanemann; Marion Schnellhardt; Michaela Niessen; Hartmut Scheel; Kay Hofmann; Erica S Johnson; Gerrit J K Praefcke; R Jürgen Dohmen
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

10.  Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome.

Authors:  Rati Verma; Robert S Oania; Natalie J Kolawa; Raymond J Deshaies
Journal:  Elife       Date:  2013-01-22       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.